ORTINLAB.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 00:13):

Stats
Today's Volume	1 872.00
Average Volume	33 375.00
Market Cap	154.09M
EPS	INR0 ( 2024-02-11 )
Next earnings date	( INR0 ) 2024-05-27
Last Dividend	INR0 ( N/A )
Next Dividend	INR0 ( N/A )
P/E	-3.75
ATR14	INR0.120 (0.63%)

Volume Correlation

Long: 0.03 (neutral)

Short: 0.96 (very strong)

Signal:(48.769) Expect same movement, but be aware

Ortin Laboratories Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ortin Laboratories Correlation - Currency/Commodity

-0.05
( neutral )

0.01
( neutral )

0.00
( neutral )

0.09
( neutral )

-0.10
( neutral )

0.06
( neutral )

Ortin Laboratories Financials

Annual	2022
Revenue:	INR60.20M
Gross Profit:	INR26.31M (43.70 %)
EPS:	INR-0.0823

FY	2022
Revenue:	INR60.20M
Gross Profit:	INR26.31M (43.70 %)
EPS:	INR-0.0823

FY	2022
Revenue:	INR82.31M
Gross Profit:	INR35.79M (43.48 %)
EPS:	INR-0.500

FY	2021
Revenue:	INR81.67M
Gross Profit:	INR42.17M (51.63 %)
EPS:	INR1.160

Financial Reports:

No articles found.

Ortin Laboratories

Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.